Problems in thinking and attention linked to COVID-19 infection
The research found that those with more severe COVID-19 symptoms scored lower on an online series of tests, with performance on reasoning and problem-solving tasks being most affected.
August 13, 2021
by worldpharmanews
‘Mix and match’ COVID-19 vaccine study yields promising results
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
June 30, 2021
by pharmatimes
Protein identified as new therapeutic anti-viral target for COVID-19
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target.
June 10, 2021
by worldpharmanews
New research identifies single biomarker that can indicate underlying neurodegeneration
New research has identified a single biomarker that can be used to accurately identify underlying neurodegeneration among people with cognitive issues.
June 9, 2021
by pharmatimes
UK government pledges £18.5m for long COVID research
The UK government has announced it will provide £18.5m to fund research projects aimed at improving understanding of the causes and effects of the longer term effects of COVID-19 – known as long COVID.
February 19, 2021
by pharmatimes
Oxford University launches Covid-19 vaccine study in children
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
February 18, 2021
by pharmaceutical-technology
UK trial will evaluate safety of mixing different COVID-19 vaccines
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.
February 4, 2021
by pharmatimes
NIHR establishes new patient recruitment research centres
The National Institute for Health Research (NIHR) has launched five national patient recruitment centres (NPRCs) to accelerate and aid life sciences companies to deliver late-stage clinical research within the NHS.
November 16, 2020
by pharmatimes
New study assessing antibiotics for COVID-19 sepsis
Researchers from an NIHR-funded study are looking at how to improve the use of antibiotics for patients with COVID-19 who are at risk of developing sepsis and thus organ failure and death.
November 4, 2020
by pharmatimes
Asthma fund launched to support development and adoption of new technologies
A new fund aiming to support the development and adoption of technology for people with asthma has been created by Asthma UK and the British Lung Foundation alongside the National Institute for Health Research (NIHR) and the Engineering and ...
October 22, 2020
by pharmatimes
NIHR review identifies long-term effects of COVID-19
A review from the National Institute for Health Research will analyse the evidence around ongoing COVID-19 symptoms, otherwise referred to as ‘Long Covid’.
October 16, 2020
by pharmatimes
NIHR, UKRI fund eight new coronavirus research projects
Eight new research projects investigating the transmission of coronavirus have been awarded a total of £5.3 million by the NIHR and UK Research and Innovation (UKRI), in the hope that findings will help shape COVID-19 policy decisions on prevention and...
September 14, 2020
by pharmatimes